Teva Pharmaceuticals Q1-2026 supplier risk profile: 344 shipments, 19 suppliers across 13 countries.
Teva Pharmaceuticals imported 344 shipments in Q1 2026 across 19 suppliers in 13 countries. The Czech Republic dominated sourcing at 30% of total shipments, led by Teva Czech SRO Opava KO with 104 shipments. Germany contributed 26% of imports, with PLIVA Hrvatska D O O and Fresenius Kabi Austria among key partners. HS Chapter 30 (Pharmaceutical products) accounted for 48% of tracked shipments, reflecting the company's core manufacturing inputs.
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
One name matching a sanctions watchlist was flagged during Q1 2026. No suppliers showed forced-labor exposure under UFLPA proximity analysis.
19 distinct tier-1 suppliers in Q1 2026
| TEVA CZECH SRO OPAVA KO | Czechia | 104 |
| PLIVA HRVATSKA D O O | Germany | 65 |
| PLIVA HRVATSKA D O O | Croatia | 44 |
| TEVA PHARMACEUTICALS IRELAND | Ireland | 27 |
| FRESENIUS KABI AUSTRIA | Germany | 26 |
| TEVA RUNCORN | United Kingdom | 18 |
| CENTRIENT PHARMACEUTICALS SPAIN | Spain | 12 |
| TEVA PHARMACEUTICAL | Israel | 9 |
Share of Q1 2026 inbound shipments by source country
15 tier-2 + 74 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.